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Chapter
Histoplasma capsulatum and 
Histoplasmosis: Current Concept 
for the Diagnosis
Emilie Guemas, Loïc Sobanska and Magalie Demar
Abstract
Histoplasmosis is a global deep mycosis caused by Histoplasma capsulatum (Hc), 
a dimorphic fungus. It exists on two main varieties Hc capsulatum and Hc duboisii 
that could be distinguished by their epidemiology, their clinical presentation, 
and the morphological aspect of the fungus at direct examination of the sample. 
Laboratory diagnosis of Hc remains a real challenge as it required experience 
and equipment. Through a general review of literature, the different diagnosis 
tools for Histoplasma sp. are analyzed, and strengths and weaknesses are pointed 
according to the context-based value. Isolation of Hc on culture is the gold stan-
dard for diagnosis of histoplasmosis. However, it remains less sensitive (sensitiv-
ity: up to 77%) and implies long time to result, which can be inappropriate or in 
adapted for an emergency diagnosis. So, nonculture methods as antigen testing, 
serology, and molecular biology become available and allow a rapid diagnosis. 
However, the optimal diagnostic method depends on many parameters as the very 
wide range of symptomatology, the immune status. Indeed, Ag detection is the 
best diagnosis tool for PHD (sensitivity: 92–95%) and SCN histoplasmosis (sen-
sitivity: 66%) and serology for the subacute/chronic form (sensitivity: 85–93%). 
Thus, the clinico-biological dialog is essential, and histoplasmosis management 
includes an integrated medical approach.
Keywords: Histoplasma capsulatum, diagnosis, non-culture methods, culture, 
performance
1. Introduction
Histoplasmosis caused by Histoplasma capsulatum leads to a wide spectrum 
of symptomatology [1–3] varying from subclinical or acute to chronic form. 
Histoplasmosis can be localized or it causes a disseminated, life-threatening infec-
tion involving various tissues and organs of the body, notably in immunocompro-
mised hosts [1, 4].
This is a thermally dimorphic fungus presenting as a yeast at body temperature 
and as a hyaline mold in the natural environment. Human histoplasmosis is due 
to the two varieties of the pathogen: H. capsulatum var. capsulatum (Hcc) and H. 
capsulatum var. duboisii (Hcd), which could be distinguished by their epidemiology, 
their clinical presentation, and the morphological aspect of the fungus at direct 
examination of the sample [3].
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Hcc, responsible for “small cell” histoplasmosis or American histoplasmosis, is 
well-documented in the United States mainly in the valleys of Ohio and Mississippi, 
South America, and Asia. Hcd responsible for “large-form” histoplasmosis or 
African histoplasmosis is endemic in Central and West Africa and Madagascar 
[3, 5–6]. We point out a third variety, H. capsulatum var. farcimimosum, involved in 
equine pathology that will not be detailed in this chapter.
Histoplasmosis can be challenging to diagnose because it is laborious and requires 
special characteristics for its revealing. According to the criteria recommended by 
the European Organization for Research and Treatment of Cancer/Invasive Fungal 
Infections Cooperative Group and the National Institute of Allergy and Infectious 
Diseases Mycoses Study Group (EORTC/MSG) and those of the Council of State and 
Territorial Epidemiologists (CSTE) [7, 8], an integrated approach including clinical, 
radiographic, and laboratory evidence is required. For laboratory diagnosis, several 
techniques are available as microbiology, histopathology, and immune-serological 
assays, depending on the clinical context and laboratory capabilities. Since 1978, the 
introduction of the Histoplasma antigen assay significantly improved the diagnosis 
by allowing a rapid, noninvasive, and sensitive method. Then, if culture remains the 
reference approach in most laboratories in endemic and non-endemic areas, non-
culture methods are developing and much more improving [2, 9–11].
This review describes the current diagnostics for the laboratory identification of 
H. capsulatum, with focus on their performance and context-based value.
2. Clinical presentations and type of histoplasmosis
For Histoplasma capsulatum var. capsulatum, the inhalation of conidia from 
the environment (bat or bird guano) leads to Histoplasmosis syndrome or asymp-
tomatic carriage in immunocompetent individuals. It can be self-limited especially 
in the lung or a progressive disseminated disease. Upon immunosuppression, the 
fungus can reactivate and be responsible for a localized or disseminated disease. 
Disseminated histoplasmosis has been classified as an AIDS-defining infection. 
There is a significant overlap of the pathophysiology and the clinical presentation as 
tuberculosis or cryptococcosis, sarcoidosis, and malignancy [1–4, 6, 12].
The histoplasmosis syndromes can be evoked according the clinical presenta-
tion, the epidemiology, and the disabled. It can be expressed as [1–2, 6]:
• A pulmonary histoplasmosis presenting as acute, subacute, chronic, or pulmo-
nary nodules.
• A progressive disseminated histoplasmosis (PDH) that mainly concerns 
some particular populations (extreme age groups, immunosuppressed people 
including AIDS/HIV, iatrogenic origin). However, immunocompetent people 
defined as without obviously immunodeficiency can develop such syndrome 
when important inoculum.
• A cerebral nervous system (CNS) histoplasmosis.
• Other clinical findings as mediastinal histoplasmosis (adenitis, granuloma, 
mediastinitis).
For Histoplasma capsulatum var. duboisii, many features remain undiscovered as 
the reservoir niche, pathogenesis, and epidemiology because of the relatively low 
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number of case reports. It expresses much more in skin and subcutaneous tissues 
than in lungs. Association as well with HIV is rare [5].
3. Types of specimens and context base value
All types of clinical specimens can be processed according to symptomatology 
[1–2, 4, 6–8]:
• Bronchoalveolar lavage (BAL), sputum, and lung biopsy should be performed 
for patients with pulmonary symptoms
• Bone marrow aspiration
• Punctures of lymph node, pus, or exudates
• Organ biopsies (lymph node, digestive tract, liver, skin, oral mucous)
• Peripheral blood (EDTA or fungal blood culture vacutainers)
• Cerebrospinal fluid (CSF)
Different microbiological approaches can be performed as on one hand myco-
logical examination (direct, culture) and molecular assays (qPCR) and, on the 
other hand, histopathology. The performances depend on the specimens tested and 
are much more details on paragraph 5.4 (Table 1).
4. Direct examination for mycology
Examination of liquid smears or fine-needle aspiration and/or tissue apposi-
tion on slides from all types of samples is carried out by staining with May-
Grünwald-Giemsa (MGG). Using 10% KOH with or without calcofluoric acid, a 
chitin-binding fluorescent stain for the fungal cell wall, the yeasts can be easily 
visualized between slide and slip cover. For some specimens as the peripherical 
blood, cerebrospinal fluid, bronchoalveolar fluid, and cytocentrifugation may be 
required [3, 13, 14].
Diagnosis is possible according to the morphology of the yeasts.
4.1 H. capsulatum var. capsulatum
Yeasts are spherical, small (2–5 μm in diameter), intensely violet colored, and 
surrounded by a clear halo. These yeasts are narrow-based budding yeast cells, usu-
ally intracellular (macrophage, histiocyte, etc.), and do not produce any filaments 
(Figure 1). The differential diagnosis includes Leishmania species, which is similar in 
size but has one kinetoplast [3, 6, 13, 14], Candida mainly glabrata and Cryptococcus 
yeast cell which is predominantly extracellular and strongly MGG stained.
4.2 H. capsulatum var. duboisii
Yeasts cells are oval and large (8–15 μm by 4–6 μm), with a “hourglass” or “figure 
eight” budding form, a thick wall and a narrow budding. They may have inside fat 
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or secretions 
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x x x x (x):
differential 
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Bone marrow x x (if associated 
PHD)








Organ biopsy (x) x
Non viable 
yeasts













Serology (x) x x X (low 
sensitivity)
x X x






+/-LBA or if 
associated PDH






(): not preferred but can be contributive, PDH: Progressive histoplasmosis disseminated, CNS: Central nervous system, BAL: Broncho-alveolar fluid.
Table 1. 
Preferred specimens for diagnosis according the histoplasmosis syndromes [1, 2].
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droplets. These yeasts are intra- or extracellular, sometimes arranged in short chains 
of 2 or 3 [3, 6, 13, 14].
Specimens as pus from abscess, draining sinuses and bone marrow lesions, 
colic biopsy, or BAL smears are relatively contributive to the diagnosis [4, 6, 15] in 
disseminated histoplasmosis.
Direct examination is inexpensive, and according to the relatively typical 
appearance of the levuriform elements, it allows to quickly and easily provide 
presumptive evidence for histoplasmosis. However, doubts may remain, and then 
it requires trained personnel and further investigations. Indeed confusion can con-
cern Hcc versus Cryptococcus sp., Candida glabrata, and Leishmania sp. and/or if the 
clinical picture is not very classical [3, 6, 13, 14] or Hcd versus Blastomyces dermatiti-
dis, which looks like another yeast cell and differs with its broad base budding.
5. Histopathology
Histopathology consists in the research for elements evocative of the yeast form 
of H. capsulatum inside tissues. Different stains can be carried out such as Gomori 
Methenamine Silver (GMS), Giemsa, or periodic acid-Schiff (PAS) stains that 
are the most relevant for the diagnosis. Hematoxylin and eosin (H&E) staining is 
insensitive to detect the presence of H. capsulatum [3, 13, 14, 16].
This concept of juggling between different stains and the description of mor-
phologies of the microorganism (shape, size variation, cell disposition) and the tissue 
(cell response) permit to distinguish other pathogens as Cryptococcus spp., Blastomyces 
dermatitis, Candida glabrata, Pneumocystis jirovecii, Coccidioides spp., Talaromyces (for-
merly Penicillium) marneffei, Leishmania spp., Toxoplasma gondii, and Trypanosoma 
cruzi. These differences are represented in Table 2.
5.1 H. capsulatum var. capsulatum (Hcc)
It usually shows a granulomatous reaction with “giant cells,” containing large 
rounded or oval-shaped elements (2–4 μm in diameter). Hcc is predominantly 
found phagocytosed within macrophages, histiocytes, and giant cells, often in 
clusters of many organisms, but sometimes they are in extracellular spaces.
Figure 1. 
Histoplasma capsulatum var. capsulatum on bone marrow smear, intramacrophagic yeast form, microscopic 
appearance, magnification ×1000 (photo by Emilie GUEMAS).
Plea e use Adobe Acrobat Reader to read this book chapter for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connecti n...Acrobat is locking documen loading.com
r
File cannot be found.
Histoplasma and Histoplasmosis
6
The yeast phase of Hcc is very similar to other pathogens and not distinctive in 
tissues from several other endemic fungi. The misidentification occurs principally 
with Candida glabrata, Penicillium marneffei, Pneumocystis jiroveci, Toxoplasma 
gondii, Leishmania donovani, and Cryptococcus neoformans [9]. However, in the 
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Hcd 6 - 12 IC Oval with halo Granulamatous 
tissue response
GMS, PAS













































































Leishmania 2 - 5 IC Oval to round
kinetoplast
MGG
IC: intracellular, EC: extra cellular, GMS: Gromori Methenamine Silver, PAS: Periodique Acid Schiff:, GE, MGG: 
May-Grunwald Giemsa.
Table 2. 
Diagnosis differential of H. capsulatum [2, 16, 13].
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confidently make a diagnosis of histoplasmosis and is indicative of active infection. 
Moreover, the immunohistochemistry reaction with H. capsulatum antibodies can 
be used to confirm diagnosis of histoplasmosis.
5.2 H. capsulatum var. duboisii (Hcc)
Hcc is large (6–12 μm) and the wall is thick and highly refractive, with a pseudo-
capsulated appearance. The yeast is easily distinguishable from the other endemic 
fungi especially Blastomyces dermatitis [8].
6. Culture
Isolation of H. capsulatum remains the gold standard for the laboratory diagnosis 
of histoplasmosis. However, it requires both BioSafety Level 3 (BSL3) facilities to be 
manipulated [17] and usually invasive methods to obtain the specimens from which 
culture can be performed.
6.1 Inoculation and culture of specimens
All specimen types can be used from superficial to deep ones.
Culture is performed on Sabouraud dextrose agar with antibiotics (chloram-
phenicol +/− gentamicin) +/− actidione that inhibits the contaminants. Other 
mediums can be used: brain heart infusion (BHI), yeast extract peptone agar (YEP 
agar) and potato dextrose agar (PDA) [3]. Mediums are incubated at 25–30°C for 
6–8 weeks.
As the rate of growth is slow, the growth of the mycelial forms usually takes 
2–3 weeks but may take up to 8 weeks. Colony is initially white and smooth and 
then becomes brown, with a granular or cottony texture. The reverse is white, yel-
low, or orange (Figure 2).
Figure 2. 
Culture of H. capsulatum on Sabouraud dextrose agar. Colony is white with a cottony texture (photo by Emilie 
GUEMAS).
Plea e use Adobe Acrobat Reader to read this book chapter for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connecti n...Acrobat is locking documen loading.com
r
File cannot be found.
Histoplasma and Histoplasmosis
8
6.2 Identification of the fungi
Confirmation of the cultured organism as H. capsulatum requires complemen-
tary tests:
6.2.1 The lactophenol cotton blue test (LPCB test)
It allows determining microscopy morphology with identification characters [18]:
• Hyphae: hyaline septated (2–3 μm in diameter),
• Characteristic macroconidia: large, thick-walled, round, typically tubercu-
late, or knobby (7–15 μm in diameter).
• Microconidia: smooth-walled spherical, pyriform (2–5 μm in diameter) on 
short branches or directly on the sides of the hyphae
The differential diagnosis includes Sepedonium sp. (Figure 3).
6.2.2 Identification with the MALDI-TOF
The identification of the colony can be carried out by matrix-assisted laser 
desorption/ionization time off light (MALDI-TOF). Mass spectrometry by MALDI-
TOF allows to confirm species accurately and quickly.
This identification technique is based upon the detection of highly abundant 
proteins in a mass range of 2–20 kDa by calculating their mass (m) to charge (z), 
m/z values. The spectrum thus obtained is compared with the reference spectra 
[19, 20].
6.2.3 The conversion from the mold to the yeast form
This can be achieved using enriched media such as BHI or blood agar plates 
incubated at 35–37°C in a CO2-enriched atmosphere [3]. However, H. capsulatum 
does not convert easily depending on many parameters [13] as nutriments and 
temperature conditions, which can explain that this experiment is increasingly 
abandoned.
6.2.4 “Historic” tests
The urease test allows the distinction between Hcc and Hcd as it reveals the 
expression of urease strongly for Hcc and weakly for Hcd at 48 hours [3, 5].
Others tests performed from the cultured fungi such as DNA hybridization 
using a highly specific commercially kit (AccProbe; Gen-Probe, Inc., San Diego, 
CA®) or the detection of specific precipitin by the exoantigen test was used in some 
laboratories [10, 13]. They were gradually replaced by less time-consuming method 
as MALDI-TOF. They will not be more detailed in this chapter.
6.3 Blood culture
The lysis centrifugation method as Isolator® system followed by the inoculation 
of the collected buffy coat [11] into an appropriate media culture has been proved 
to be the most efficient for detecting Histoplasma in the blood in comparison with 
other methods such as conventional or automated methods such as Bactec MYCO/F 
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Lytic bottle [21]. However, many laboratories preferred those alternative systems 
than the manual isolator system because they permit less pre-analytic processing 
and continuous automated monitoring of bottles for growth when automated [9].
6.4 Performances of the culture
The sensitivity of culture depends on the clinical manifestation, the clinical 
specimen, the state of immunity of the host, and the burden of disease [2, 9, 14]. 
Sensitivity is lower for patients with acute pulmonary histoplasmosis (40%) than 
for patients with disseminated histoplasmosis (75%) [2, 9, 10].
The diagnosis of disseminated histoplasmosis blood culture processed by lysis 
methodology and bone marrow shows higher sensitivity (60–90%). Conversely, 
respiratory samples presented poor sensitivity (0–60%) [2, 9, 10].
The limitations of the culture are the time frame for diagnosis, the mycological 
expertise required, and safety. Several weeks for growth of the fungus to establish 
the diagnosis are not consistent with the severity of the disease in immunosup-
pressed patients. Moreover, H. capsulatum poses an infectious risk and must be 
manipulated in a laboratory with BSL3.
Conversely, detection of H. capsulatum by automated methods such as the Bactec 
system has not shown optimal results with sensitivity of less than 50% [2, 9–11, 13, 
14] in acute and disseminated histoplasmosis that need to be rapidly diagnosed for 
the prompt initiation of therapy.
7. Antibody detection
Several protocols do exist based on Histoplasma-specific antibody detection 
with three routinely used assays: immunodiffusion test (ID), fixation complement 
test (FC), and indirect immunological assays (EIA) [9–11, 13, 14, 22–26]. Serology 
aims to confirm a previously contact with the pathogen, and it usually does not 
mean that the patient is making an acute infection. For histoplasmosis, in certain 
circumstances, serology can detect the acute phase of histoplasmosis. It is reported 
Figure 3. 
Histoplasma capsulatum, microscopic appearance with LPCB test, magnification ×400 (photo by Emilie 
GUEMAS).
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that the antibodies detection period is between 4 and 8 weeks but can be negative in 
immunodeficient patients [10, 14]. The serologic targets are the specific Histoplasma 
proteins M (a catalase) and H (a β-glucosidase) that are present in the entire yeast 
or an antigenic extract (histoplasmin or HMIN) used as deglycosylate or not, from 
mycelial culture. Another protein can be targeted, the protein C (a carbohydrate, 
galactomannan), that is less specific and can be responsible of cross-reactions with 
other fungi [9]. Their characteristics are summarized in the Table 3.
7.1 Immunodiffusion (ID)
Immunodiffusion assay qualitatively detects the precipitating antibodies to 
antigens M and H on agar gel. The H band appears after the M band, and the pres-
ence of both bands is highly significant for histoplasmosis diagnosis. Thus, M band 
is detectable in most patients with acute infection and persists for long periods of 
time up to 3 years after disease resolution and is often present in chronic forms 
[9, 10, 14]. It does not distinct between active from latent or resolved infection. H 
band is less frequent, confirms acute infection only in 7% according [13], remains 
present 1–2 years after disease resolution, and indicates a more severe form of the 
disease. This method is simple, reliable, and inexpensive.
7.2 Complement fixation (FC)
Complement fixation method quantitatively measures the presence of complex 
antigen antibodies in a patient’s serum against the entire yeast form or mycelial 
antigen (HMIN) from 3 to 6 weeks following infection [13]. Interlaboratory results 
vary as it is entirely strain-dependent for the antigen preparation. It is quite more 
sensitive bus less specific than the ID. Indeed, it presents numerous cross-reactions 
with other fungi and interference with rheumatoid factor and cold agglutinins [13]. 
A threshold defined as up to 1:32 or titer a 4-fold rise indicates an active infection.
7.3 Enzyme-linked immunosorbent assay (ELISA)
This method does not allow differentiation between an active infection and 
an old infection. Indeed, antibodies require 4–8 weeks to become detectable 
in peripheral blood. Serology is unreliable in patients with a reduced ability to 
produce antibodies, and then it is often negative in immunocompromised patients 
[13, 14]. Antibody testing is most useful for subacute and chronic forms of 
 histoplasmosis [2].
7.4 Western blot
Western blot immunoassay uses Ag proteins of different kDa that will complex 
with the specific Histoplasma antibodies on a nitrocellulose band. It showed good 
results but does not exist as a commercial kit, so it can be fastidious to set up. The 
sensibility is improved by the treatment of the Ag (Histoplasmin) [22].
7.5 Other tests
Interferon gamma release assay (IGRA): this test is based on the quantification 
of lymphocyts-released interferon (IFN) -γ after restimulation in vitro of the cell-
mediated immunity with the same specific antigens. Recently, Rubio-Carrasquilla 
et al. [23] considered it as a promising screening method to detect individuals with 
latent Hc infection, even decades after the primary infection.
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Immunodiffusion (ID) ELISA Western Blott
Mechanisms A supplemented specific 
Ag induces Ag-Ab 
complexes
Precipitins Ac-Ag (H/M) on 
gel agar
Indirect sandwich ELISA Visualisation of band profiles on 
nitrocellulose membranes
Type of Ag Entire yeast or HMIN HMIN
Prot M, Prot H
Yeast cell extract, ribosome, HMIN (glycosylayte/
deglycosylate)
Histoplasma antigens of 115, 91,88, 
83, 70 and 38 kDa from HMIN 
(glycosylayte/deglycosylate)
delay 3 -6 weeks 4-6 weeks
IgG anti-M → IgG M+H
2 -4 weeks 2-4 weeks






Prot M: up to 3 years Months to years Months to years
Prot H: 1-2 years
Sensitivity 72-95% 70-95% 75-100% 45-100%
Specificity 70-80% 100% 91-100% 94-100%
Histoplasmosis 
meningitidis
When positive (culture 
usually negative (63%)






Acute infection ++ Band M (80%)
Band H (7-20%)
66-100% (9-10, 13) 45-94% (13, 22)
Chronic infection + Band M 90% (9-10, 13) 94-100% (13, 22)
Special remarks Interference with 
Rheumatoid factor and 
cold agglutinins
Positive after skin test 
Histoplasmine (M +++/H+)
Ribosome antigen and ptHMIN induces better 
response than glycosylate HMIN antigene. Best 
results with ELISA using ferrous metal
Better results when using ptHMIN
Can detect early in the infection
Kits/tests House-made tests House-made tests House-made tests
Commercialized tests with IgG, IgM, IgA
House-made tests
Histoplasmine : HMIN, deglycosylated HMIN: tpHMIN.
Table 3. 
Summary of serological assays [2, 9, 10, 13, 14, 22, 26].
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Latex agglutination tests were developed as a commercial kit, but false positives 
results were found in patients with tuberculosis. It was compared as more sensitive 
than CF [13].
A hemagglutination test was available but failed to differentiate B. dermatiti-
dis [13].
A recent meta-analysis [9] interested in the global sensitivity of antibody 
detection for disseminated histoplasmosis and showed a low sensitivity of 58% in 
contrast with high specificity (100%). But there is a real distinction between the 
different assays. WB and ELISA methods have the highest analytical performance, 
with sensitivity of up to 90% when used in ptHMIN. This can explain that it is 
relevant to associate different methods in order to improve the diagnosis.
Cross-reactivity with granulomatous disease, tuberculosis, and sarcoidosis can 
occur with immunodiffusion and complement fixation tests. Moreover, serologic 
cross-reaction can occur with other common fungal pathogens like Blastomyces 
dermatitidis, Coccidioides immitis, Aspergillus fumigatus, and Paracoccidioides brasil-
iensis [24, 25].
The presence of antibodies in the CSF allows making the diagnosis of 
Histoplasma meningitis [2, 26].
8. Antigen detection
8.1 Target antigens
8.1.1 Specific-Histoplasma antigen detection
Circulating specific-Histoplasma polysaccharide antigen (HPA) detection is a 
useful option for diagnosis [9, 13–14, 27–28]. Histoplasma galactomannan is the 
target of the antigenic detection. Since its introduction in 1986 [13–14], as a solid-
phase radioimmunoassay, it was developed into a sandwich enzyme immunoassay 
(EIA) [2, 13, 27–29] with different improved generations and recently into a lateral 
flow assay (LFA) [30]. Their performance is related to the choice of the antibod-
ies used monoclonal versus polyclonal, and the conjugate (Biotine or horseradish 
peroxidase) [13].
8.1.2 Galactomannan antigen detection
This polysaccharide mostly found in the cell wall of Aspergillus sp. is commonly 
used for invasive aspergillosis diagnosis in high-risk immunosuppressed patients 
suffering of solid organ transplantation or hematological malignancies. Cross-
reactivity with the histoplasma antigen detection is reported suggesting that this 
test could be a potentially helpful diagnostic test for histoplasmosis in HIV-infected 
patient because of the low incidence of invasive aspergillosis in this population. The 
sensibility of this test for diagnosis of disseminated histoplasmosis in AIDS patients 
is 77% and specificity is 100% [31].
8.2 Technical methods
8.2.1 Enzyme immunoassay (EIA)
This noninvasive method can be performed in urine, serum, and other body 
fluids as LBA [2, 9, 10, 13–14] and is the simplest diagnostic method, easily imple-
mented in low- and middle-income countries.
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It allows a rapid diagnosis especially for immunosuppressed patients with 
severe acute or disseminated histoplasmosis. It is less sensitive than serology for the 
diagnosis of subacute and chronic pulmonary histoplasmosis [2, 9].
Antigen detection in urine is more sensitive than in serum for the diagnosis of 
disseminated histoplasmosis (95% versus 86% for HIV-infected patient) [9, 10–11]. 
However, antigen detection in urine is less useful for pulmonary forms or chronic 
histoplasmosis.
This method has also been applied to other body fluids, including BAL for 
patient with pulmonary symptomatology and CSF for Histoplasma meningitis. 
Antigen was detected in the CSF of 66% of immunosuppressed-infected patient 
patients who had Histoplasma meningitis [26].
If useful for the diagnosis, it can also monitor the antigen clearance, particularly 
in serum and thus appears as an useful marker for treatment response [32].
Moreover, it has proven its applicability to infected animals that may act as 
potential reservoirs for humans [28, 29].
Cross-reactivity of antigen testing occurs in patients who have other fungal 
infections, including infections by Blastomyces dermatitidis, Paracoccidioides brasil-
iensis, and Penicillium marneffei [33]. The most problematic issue is differentiating 
histoplasmosis and blastomycosis because the geographic areas overlap.
8.2.2 Lateral flow assay (LFA)
Recently, a lateral flow assay (LFA) has been developed and evaluated for rapid 
diagnosis of histoplasmosis. This point of care antigen detection in serum allows 
rapid results with high analytical performance. It is based on the using of rabbit 
polyclonal antibody that recognizes galactomannan antigen of H. capsulatum. 
Indeed, sensitivity is under 95% and specificity is 90%. Cross-reactivity occurs 
principally with paracoccidioidomycosis [30].
9. Molecular tests
9.1 Polymerase chain reaction (PCR)
Molecular methods can improve and accelerate the histoplasmosis diagnosis 
with a high analytical sensibility and specificity [9, 10, 34–36]. This combined with 
turnaround times shorter than those of other diagnostics. It is much more safety 
and reduces the risk of laboratory acquired histoplasmosis when handle its positive 
culture. Several applications can be linked to the use of PCR based techniques as (i) 
human diagnosis from different samples, with an increasingly use for the imported 
cases diagnosis in non-endemic areas [9–11, 13], (ii) environmental exploration for 
revealing the histoplasmosis reservoir [35], (iii) and prevention policies and strate-
gies for exposure risk [2].
There are no currently official approved molecular assays for H. capsulatum that 
are directly applicable to clinical specimens and no commercially kits are available 
[9, 10, 34]. However, there are numerous reports of the laboratory-developed PCR 
assays (in house PCR) using the different type of PCR (conventional, nested and 
quantitative) and a variety of molecular targets. The most relevant are the Internal 
Transcribed Spacer (ITS) multicopy region of the ribosomal DNA, genes encoding 
the M antigen or the 100-kDa-like protein [9, 34]. Most studies in the literature 
evaluated the performance of nested PCR in the diagnosis of PDH, this assay is 
associated with the increased risk of amplicon contamination, because of the 
manipulation of amplified products.
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A multiplex approach can also be performed. For example, in a reference labora-
tory in Spain they developed a multiplex qPCR for H. capsulatum, Pneumocystis 
jirovecii and Cryptococcus neoformans [11].
As a full tool to Histoplasmosis diagnosis, molecular assays can be performed 
on different types of specimens including respiratory secretions, biopsies, bone 
marrow, blood, or sera.
For diagnosis of disseminated histoplasmosis (PDH), sensitivity and specificity 
are 95% and 99%, respectively [2, 9]. Sample of blood and bone marrow have an 
excellent sensitivity (100%) in immunocompromised patients with disseminated 
histoplasmosis, whereas it is weaker in immunocompetent patients [2, 11].
Moreover, sensitivity increases by testing more than one sample per patient in 
cases with extra-pulmonary histoplasmosis. So, in case of high suspicion, clinicians 
should repeat and diversify samples [2, 9, 11, 34].
Recent findings in molecular biology permit to evaluate genetic diversity using 
multilocus sequence typing (MLST) OR RAPD-PCR [36]. This could be Interesting 
to associate genotypes and clinical presentation.
9.2 Loop-mediated isothermal amplification (LAMP)
9.2.1 Principe
Loop-mediated isothermal amplification (LAMP) is a highly efficient, sensitive, 
specific and cost-effective isothermal amplification method that uses at least four 
primers, recognizing six different regions in the target sequence (Figure 4) and 
results in a self-primed DNA [37].
In LAMP, the target sequence is amplified at a constant temperature of 60–65°C 
using either two or three sets of primers and a polymerase with high strand dis-
placement activity in addition to a replication activity. The amount of DNA pro-
duced in LAMP is considerably higher than PCR-based amplification.
To increase the reaction sensitivity, the ITS region was used as target, since it 
is a multicopy sequence and also because it is considered an important barcoding 
sequence for fungal identification, being conserved among H. capsulatum strains 
and divergent from other fungi, ensuring high specificity.
Forward inner primer (FIP) and backward inner primer (BIP) have inverted 
sequences attached at the 5′ end, named F1c and B1c, which are complementary to 
an internal sequence from the amplified strand, forming a loop at each extremity of 
a single strand DNA.
The outer primers (F3 and B3) anneal upstream to the FIP and BIP, acting as a 
binding site for DNA polymerase, which, in the LAMP reaction, also contains the 
strand displacement activity.
LAMP results can be observed using several strategies with minimal ambiguity 
with real-time turbidimetry (magnesium pyrophosphate formation), fluorescent 
compounds (Sybr Green, Eva Green, SYTO, calcein), magnesium colorimetric 
titration, fluorescent-labeled probes, quencher-labeled primers, dye-labeled prim-
ers, and PH-sensitive dyes.
9.2.2 Indications
LAMP can be used on samples of whole blood or bone marrow for patients 
suspected of progressive disseminated histoplasmosis (PDH).
A new assay, the so-called ITS LAMP, showed no cross-reactivity when assayed 
with DNA from other pathogenic or environmental fungi. The assay is able to detect 
isolates from all geographical clades of H. capsulatum, including Hcd. In comparison 
with Hcp100 nPCR, it reached sensitivity of 83% and specificity of 92% [35].
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This method remains cost-effective with or without the extraction DNA step 
and did not require a thermocycler or an electrophoresis apparatus. It saves time 
with test performed in less than 200 minutes [35]. However, this little-known and 
recent method is currently underused and much more reserved for resource-limited 
laboratories. It should evolve in the next years to come and need further evaluation 
to be routinely used.
10. Summary of the different categories of tests and their sensitivity (%)
The performance for each test according the clinical context is summarized in  
Table 4. It considers global sensitivity without any distinction between the differ-
ent protocols (antigen preparation, methods, ...).
It highlights that Ag detection is the best diagnosis tool for PHD and SCN histo-
plasmosis, serology for the subacute/chronic form, and the culture although this is 
the reference method remains less sensitive.
11. Conclusion
Histoplasmosis remains a severe and neglected disease for which early diagnosis 
of invasive fungal infections is critical to allow a prompt patient care. Indeed the 
mortality rate among HIV/AIDS patients diagnosed with histoplasmosis is high: 
42% mortality for disseminated histoplasmosis if treatment is delayed and 100% if 
antifungal therapy is not prescribed.
Figure 4. 
Principe of LAMP [38].
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The gold standard for histoplasma diagnosis remains culture. It’s a time-
consuming process and has limitations in sensitivity. Moreover, it requires invasive 
procedure and mycological expertise.
Nonculture methods have been developed to improve and accelerate diagnosis 
of histoplasmosis, such as histoplasma antigen detection, antibody detection, 
and molecular biology. It should have conjunction between the different tools of 


















92 95 83 30 88 5 66
81 31
Serology 75 58 64 95 83 83 59
63 54
Pathology 76 NE 20 42 75 75





PDH: Progressive histoplasmosis disseminated, CNS: Central nervous system, NE: Non evaluated.
Table 4. 
The different performances (sensibilité %)of the methods are summarized in this table adapted to azar et al. 
(2), Caceres et.al (9) and Wheat et.al (26).
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